( Madison Wis. - Pfizer spent abou...)Failure of heart drug offers lessons for drug industry

Madison, Wis. - Pfizer spent about $800 million to develop torcetrapib, a heart drug that seemed like a blockbuster until people began to die in clinical trials. Hours after learning the drug was irreversibly flawed, the company called a halt to further trials, a decision that sent its stock downward and put thousands of job......

Full article >>>
'"/>

Source:wistechnology.com By Tom Still 12/12/06


Page: 1 2 3
Related biology technology :

1. Router Failure and Software Crash UW-Madison Network
2. Primary cells, rat heart endothel
3. Primary cells, rat heart muscle
4. UW tests adult stem cell role in regenerative heart care
5. InvivoSciences receives NIH grant for heart technology
6. FDA approves GEs heart-imaging technology
7. Biotech firm uses live heart tissue in drug screens
8. Aurora team implants Wisconsins first total artificial heart
9. Medical College researchers receive new grants to enhance discovery of heart-protecting anesthetics
10. UW-Madison puts heart and mind into stem cells
11. Technology helps heal heart arrhythmias in children